Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...
8d
News-Medical.Net on MSNBreakthrough study defines ideal interval for immunotherapy and liver transplantsHepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new cases and 830,200 deaths were registered in 2020 according to the World ...
News Medical on MSN22d
Vimseltinib Approved by FDA for Tenosynovial Giant Cell TumorThe investigators reported that 67% of patients receiving vimseltinib had measurably reduced tumor volume, compared with none in the placebo group. Additionally, patients in the trial who received ...
The Human Tumor Atlas Network leverages scientific collaboration to integrate samples, analytical modalities and tools into detailed atlases of tumor evolution. Expanding our spatial understanding ...
The investigators reported that 67% of patients receiving vimseltinib had measurably reduced tumor volume, compared with none in the placebo group. Additionally, patients in the trial who received ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results